Atlas Trials

Avirmax Biopharma Inc

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Avirmax Biopharma Inc

RecordFirmDate
Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intravitreal (IVT) Injection of ABI-110 (AAV2.N54-VEGF Trap) in Subjects With Neovascular (Wet) Age-Related Macular Degeneration (wAMD), Including Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) (NCT06550011)Avirmax Biopharma Inc2024-08-07

Track Avirmax Biopharma Inc automatically

Every clearance here is in the API, with alerts when new ones post.